SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Ernexa Therapeutics Inc. (ERNA)
Score window: May. 30, 2025 to May. 29, 2026

Back View Correspondence
Probe Score
2.5 / 10
Letters
2
Latest Activity
Jun. 16, 2025
Version
v1

Score Breakdown

Letter Count
2.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Mar. 26, 2026 CORRESP Neutral/Informational Moderate Ernexa Therapeutics Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-3. They are seeking to have the reg… Read Filing EDGAR
Mar. 20, 2026 UPLOAD Neutral/Informational Low The SEC has notified Ernexa Therapeutics Inc. that it will not review their registration statement filed on March 16, 2026. The letter emphasizes that the responsibility for the a… Read Filing EDGAR
Jun. 16, 2025 CORRESP Neutral/Informational Moderate Ernexa Therapeutics Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-3, which was filed on June 11, 2025… Read Filing EDGAR
Jun. 16, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to Ernexa Therapeutics Inc. that they will not review the company's registration statement filed on June 11, 2025. The SEC emphasizes that the responsibil… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.